| | | 54275 | | 31.07.1997 | | Novartis Pharma Schweiz AG | | 26.01.2006 | | | | | | | | | | | 01.99. | | | | 01.99. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 03 | Exelon 1,5 mg | Kapseln | Capsules (Rivastigmine 1.5 mg) | N06DA03 | CI | | 04 | Exelon 3 mg | Kapseln | Capsules (Rivastigmine 3 mg) | N06DA03 | CI | | 05 | Exelon 4,5 mg | Kapseln | Capsules (Rivastigmine 4.5 mg) | N06DA03 | CI | | 06 | Exelon 6 mg | Kapseln | Capsules (Rivastigmine 6 mg) | N06DA03 | CI |
|
|
